A Study of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Primary Sjögren’s Syndrome September 18, 2019https://www.clinicaltrials.gov/ct2/show/NCT04078386 A Study of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Primary Sjögren’s Syndrome
